Comments on: Silibinin from milk thistle inhibits lung, prostate cancer in mice http://psa-rising.com/blog/index.php/2006/06/29/silibinin-from-milk-thistle-inhibits-lung-prostate-cancer-in-mice prostate cancer news Mon, 03 Dec 2007 09:35:49 +0000 http://wordpress.org/?v=2.1.3 By: Patrick OShea http://psa-rising.com/blog/index.php/2006/06/29/silibinin-from-milk-thistle-inhibits-lung-prostate-cancer-in-mice#comment-467 Patrick OShea Mon, 10 Jul 2006 17:06:34 +0000 http://psa-rising.com/blog/index.php/2006/06/29/silibinin-from-milk-thistle-inhibits-lung-prostate-cancer-in-mice#comment-467 Silibinin is often thought to be the major active part of silymarin. Thus, the relatively large number of silibinin studies. However, silymarin also contains isosilybins (A & B). These are none present in silibinin extracts. Davis-Searls, et al, (Cancer Research, Vol 65, 4448-57, May 15, 2005) showed that isosilybin B (5% of silymarin) was the most potent inhibitor of LNCaP, PC-3 & DU 145 cells. A silymarin supplement might be preferable to pure silibinin. Silibinin is often thought to be the major active part of silymarin. Thus, the relatively large number of silibinin studies. However, silymarin also contains isosilybins (A & B). These are none present in silibinin extracts. Davis-Searls, et al, (Cancer Research, Vol 65, 4448-57, May 15, 2005) showed that isosilybin B (5% of silymarin) was the most potent inhibitor of LNCaP, PC-3 & DU 145 cells.

A silymarin supplement might be preferable to pure silibinin.

]]>